deltatrials
Completed NA INTERVENTIONAL 2-arm NCT06686823

Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment

Effects of a Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment: A Randomized Controlled Trial

Sponsor: University of Salamanca

Conditions Breast Cancer Cancer-related Cognitive Impairment Clinical Trials Cognitive Training Everyday Cognition Oncology
Interventions Cognitive Training Program Health Education Program
Updated 2 times since 2024 Last updated: Feb 10, 2026 Started: Dec 1, 2024 Primary completion: Oct 1, 2025 Completion: Oct 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Cancer-related Cognitive Impairment and is currently completed. University of Salamanca leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2024 – ~Feb 2026 · 14 months · monthly snapshotNot Yet Recruiting~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed NA

    Status: Not Yet Recruiting → Completed

  2. Dec 2024 — Feb 2026 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Salamanca
Data source: University of Salamanca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations